Clinical Trials Browser

Phase 2 × Hypereosinophilic Syndrome × Granulocyte Colony-Stimulating Factor × Clear all

NCT00483067 2012-08-02

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Hypereosinophilic Syndrome